335 related articles for article (PubMed ID: 29294212)
21. Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433).
Kumari S; Ahsan SM; Kumar JM; Kondapi AK; Rao NM
Sci Rep; 2017 Jul; 7(1):6602. PubMed ID: 28747713
[TBL] [Abstract][Full Text] [Related]
22. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy.
Song S; Mao G; Du J; Zhu X
Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687
[TBL] [Abstract][Full Text] [Related]
23. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
24. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
25. Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphic Analyses.
Khan A; Imam SS; Aqil M; Ahad A; Sultana Y; Ali A; Khan K
Mol Pharm; 2016 Nov; 13(11):3773-3782. PubMed ID: 27661966
[TBL] [Abstract][Full Text] [Related]
26. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model.
Brem S; Tyler B; Li K; Pradilla G; Legnani F; Caplan J; Brem H
Cancer Chemother Pharmacol; 2007 Oct; 60(5):643-50. PubMed ID: 17256133
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
[TBL] [Abstract][Full Text] [Related]
28. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q
Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456
[TBL] [Abstract][Full Text] [Related]
29. Differential pro-apoptotic effects of synthetic 4-thiazolidinone derivative Les-3288, doxorubicin and temozolomide in human glioma U251 cells.
Коbylinska LI; Klyuchivska OY; Grytsyna II; Finiuk N; Panchuk RR; Starykovych MO; Lehka L; Lesyk RB; Zіmenkovsky BS; Stoika RS
Croat Med J; 2017 Apr; 58(2):150-159. PubMed ID: 28409498
[TBL] [Abstract][Full Text] [Related]
30. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
31. Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy.
Chen Z; Lai X; Song S; Zhu X; Zhu J
Drug Deliv; 2016 May; 23(4):1369-73. PubMed ID: 26017099
[TBL] [Abstract][Full Text] [Related]
32. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
[TBL] [Abstract][Full Text] [Related]
33. Surface modified dendrimers: synthesis and characterization for cancer targeted drug delivery.
Sharma A; Gautam SP; Gupta AK
Bioorg Med Chem; 2011 Jun; 19(11):3341-6. PubMed ID: 21570304
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells.
Kesharwani P; Xie L; Banerjee S; Mao G; Padhye S; Sarkar FH; Iyer AK
Colloids Surf B Biointerfaces; 2015 Dec; 136():413-23. PubMed ID: 26440757
[TBL] [Abstract][Full Text] [Related]
35. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas.
Sasajima T; Ono T; Shimada N; Doi Y; Oka S; Kanagawa M; Baden A; Mizoi K
Nucl Med Biol; 2013 Aug; 40(6):808-15. PubMed ID: 23701701
[TBL] [Abstract][Full Text] [Related]
36. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent.
Agarwal A; Gupta U; Asthana A; Jain NK
Biomaterials; 2009 Jul; 30(21):3588-96. PubMed ID: 19344947
[TBL] [Abstract][Full Text] [Related]
37. Temozolomide loaded nano lipid based chitosan hydrogel for nose to brain delivery: Characterization, nasal absorption, histopathology and cell line study.
Khan A; Aqil M; Imam SS; Ahad A; Sultana Y; Ali A; Khan K
Int J Biol Macromol; 2018 Sep; 116():1260-1267. PubMed ID: 29775717
[TBL] [Abstract][Full Text] [Related]
38. Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer.
Gao S; Li J; Jiang C; Hong B; Hao B
Drug Des Devel Ther; 2016; 10():1-11. PubMed ID: 26719669
[TBL] [Abstract][Full Text] [Related]
39. RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma.
Zhang L; Zhu S; Qian L; Pei Y; Qiu Y; Jiang Y
Eur J Pharm Biopharm; 2011 Oct; 79(2):232-40. PubMed ID: 21496485
[TBL] [Abstract][Full Text] [Related]
40. The use of TMZ embedded hydrogels for the treatment of orthotopic human glioma xenografts.
Adhikari B; Li J; Brandel MG; Futalan D; Akers J; Deming T; Chen CC; Carter BS
J Clin Neurosci; 2017 Nov; 45():288-292. PubMed ID: 28867360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
